Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Labcorp Holdings (NYSE:LH) launched the first FDA cleared ...

In February 2026, Labcorp announced nationwide availability of the Elecsys pTau-181 blood test, the first FDA-cleared primary-care tool to aid in ruling out Alzheimer’s disease by identifying ...

Labcorp is a science and healthcare company that provides laboratory testing services worldwide. It also functions as a lab facility that conducts research, clinical studies, diagnostic testing, and ...

Labcorp, one of the country’s largest providers of diagnostic medical testing services, announced today that it will offer the only blood test cleared by the U.S. Food and Drug Administration to aid ...

Labcorp Holdings said it would soon offer a blood test for diagnosing Alzheimer's disease in primary-care settings. The Burlington, N.C., lab-services company on Thursday said the Elecsys pTau181 test ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min As the number of Americans at ...

BURLINGTON, N.C., Aug. 18, 2025 /PRNewswire/ -- Labcorp, a global leader of innovative and comprehensive laboratory services, announced today the availability of the Lumipulse® pTau-217/Beta Amyloid ...

NEW YORK – With its new Test Finder software tool developed in collaboration with Amazon Web Services (AWS), Laboratory Corporation of America aims to streamline test ordering for clinicians. Launched ...

Diagnostics giant Labcorp has introduced Test Finder, a generative AI tool developed in conjunction with Amazon Web Services (AWS). Test Finder aims to simplify lab test selection by permitting ...

Labcorp announced yesterday a new AI tool called Test Finder to help doctors speed up their ability to locate the right lab tests. Built with Amazon Web Services, the system lets clinicians type or ...